699 results found

On May 16, the Supreme Court distributed the CareDX cert petition for consideration at the June 1 conference since the Respondents waived filing a reply.

The USPTO has published an apparently January 2020 Commissioner Decision effectively precluding the filing of patent applications where the invention was made solely by artificial Intelligence (AI).

On October 26, 2018, the International Trade Commission issued the public version of its opinion (part 1 and part 2) in Certain Non-Volatile Memory Devices and Products Containing the Same (Inv. No. 337-TA-1046).

「特定の」塩の組み合わせを強調して反論を行ったために包袋禁反言（審査経過に基づくエストッペル）が適用された事例 出願審査におい&#

Oracle's decade-long copyright infringement suit against Google may be heading to the Supreme Court.

治療方法クレームの101条特許適格性を認めた判例としてVanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Ltd., 887 F.3d 1117 (Fed. Cir. 2018)があります

In Part I of this series on Disclosing AI Inventions, we discussed the basics of machine learning and the unique disclosure challenges presented by the "black box" nature of trained machine...

Terminology such as Artificial Intelligence (AI) and Machine Learning (ML) have become commonplace – much like "text message," "email," and "smart device."

On March 11, 2022, ALJ Monica Bhattacharyya issued a notice of her initial determination ("ID") of violation of section 337 in Certain Electrical Connectors and Cages, Components Thereof, and Products Containing the Same (Inv. No. 337-TA-1241).

The Ninth Circuit recently affirmed a $3,938,227.22 attorney's fees award in the contract and copyright dispute between UM Corporation ("UMC") and Tsuburaya Products Co.

Colgate-Palmolive Co. appealed the Examiner's rejection of U.S. Application No. 15/539,725 (filed June 26, 2017) as indefinite under 35 U.S.C. §112(b)...

Raytheon appealed a final inter partes review decision of the Patent Trial and Appeal Board finding claims 3 and 16 of US 9,695,751 unpatentable as being obvious in view of the Knip reference.

For practitioners at the USPTO, the reversal of a 101 rejection in Ex parte Patil (PTAB January 7, 2021), APJs Grimes, Scneider and Valek

On July 11, Teva filed its petition for certiorari from the Federal Circuit's second decision in its "skinny label" litigation with GSK, 7 F.4th 1320 (Fed, Cir. 2022).

As previously discussed in this blog (see Creation vs. Conception: Can an AI Machines be an Inventor?) some AI researchers believe that the output of certain sophisticated AI software...

Illumina, Inc. and Sequenom, Inc. ("Illumina") filed suit against Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc., and Roche Molecular Systems, Inc. ("Roche") alleging infringement of U.S. Patents 9,580,751...

In the matter Ex parte MICHAEL J. WEST, in Technology Center 1700 (USSN 16/078,845; Appeal 2023-003903) rejections for an alleged lack of patentable subject matter, a lack of enablement, indefiniteness, and obviousness...